Data as of Oct 24
| +4.86 / +3.59%|
The 18 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 177.00, with a high estimate of 195.00 and a low estimate of 125.00. The median estimate represents a +26.05% increase from the last price of 140.42.
The current consensus among 19 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.